Diligence memo · auto-generated · as of July 2, 2026
Confluence Life Sciences, Inc.
Confluence Life Sciences, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Confluence Life Sciences, Inc. operates in Other Health Care, based in SAINT LOUIS.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Confluence Life Sciences, Inc. has raised $5.7M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $4.8M on 2016-04-08.
Most recent recorded round closed around 2016-04-08.
Valuation (modeled)modeled
Provath models Confluence Life Sciences, Inc. at approximately $98M (range $6.2M–$530M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.81× the median modeled value of Series A Other Health Care companies in 2016–2018 (157 peers) — value vs value, same stage and era. Within the normal band (81% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 66 months.
Last raise 10.2 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 5.4× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 67% of Other Health Care peers (5377 compared).
Modeled value ranks above 78% of those peers.
Closest niche peers: HemoSonics, LLC, Airxpanders Inc, Mercator Medsystems Inc, Simple Contacts Inc., AVG Holdings, Inc..
Peoplefiled
10 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.